from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0921/-

LFCtreatmentdescriptionclass of inhibitor

0.016

Amikacinug/mL Amikacintranslation

-0.318

Cap5-10ug/mL Capreomycintranslation

-0.420

Rox10-50 ug/mL Roxithromycintranslation

-0.001

SM2-5 ug/mL Streptomycintranslation

-0.081

Tet5-10 ug/mL Tetracyclinetranslation

1.076

Rif0.2-5ug/mL Rifampicintranscription

0.314

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.885

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.176

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.611

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.753

Clofazimine10-13 ug/mL Clofaziminerespiration

-1.035

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.014

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.186

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.043

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.971

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.245

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.384

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.144

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.883

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.871

KCN5-20 ug/mL Potassium cyaniderespiration

-0.450

NaN30.2-2 mM Sodium aziderespiration

-1.099

Nigericin50 uM Nigericinrespiration

0.127

TRC10-150 ug/mL Triclosanrespiration

-0.584

TRZ10-25 ug/mL Thioridazinerespiration

1.245

Valinomycin0.5-10 uM Valinomycinrespiration

-1.866

ZnSO42 mM ZnSO4respiration

1.272

menadione6-10 ug/mL Menadionerespiration

-0.439

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-1.015

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.391

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.999

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.845

NRP_1Non-replicating persistence stage 1dosRassociated

0.012

Amp0.2mg/mL AmpicillincellWall

-0.673

Cephalexin20-100 ug/mL CephalexincellWall

-0.191

Cerulenin0.32-5 ug/mL CerulenincellWall

0.955

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.329

EMB10-20 ug/mL EthambutolcellWall

-0.146

Eta12-40 ug/mL EthionamidecellWall

-0.101

INH0.2-0.4 ug/mL IsoniazidcellWall

0.266

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.803

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-2.423

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.876

BZA0.12 mg/mL BenzamidearomaticAmides

0.630

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.623

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.888

H2O24 mM hydrogen peroxideDNAdamaging

0.642

Levo10 ug/mL LevofloxacinDNAdamaging

0.409

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.860

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.086

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.287

UVUV-irradiationDNAdamaging

0.619

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.284

Antimycin12.5-50 ug/mL Antimycin A?

-1.036

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.283

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.372

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.208

PA8240.2-2 ug/mL PA-824?

0.365

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.323

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.373

Verapamil50 uM Verapamil?

-0.324

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.500

methoxatin10-20 ug/mL Methoxatin?